Table 2.

Clinical trials of current preventive tuberculosis vaccine candidates in children.

Name	Identifiera	Objective	Locations	Status
VPM1002	NCT01479972	To evaluate the safety and immunogenicity of VPM1002 in comparison with BCG in newborn infants	South Africa	Completed
	NCT02391415	To evaluate the safety and immunogenicity of VPM1002 in comparison with BCG in HIV-exposed/-unexposed newborn infants	South Africa	Recruiting participants
MVA85A	NCT00953927	To evaluate the safety, immunogenicity and efficacy of MVA85A in BCG vaccinated infants without tuberculosis or HIV infection	South Africa	Completed
Crucell Ad35(AERAS-402)	NCT01198366	To evaluate the safety and immunogenicity of AERAS-402 in BCG-vaccinated, HIV-uninfected infants without evidence of tuberculosis	Kenya, Mozambique, South Africa	Completed.
Hybrid 4/IC31	NCT01861730	To evaluate the safety and immunogenicityof Hybrid 4+IC31 in BCG-vaccinated infants	South Africa	Recruiting participants
	NCT02075203	To evaluate the safety, immunogenicity, and prevention of infection with Mycobacterium tuberculosis of Hybrid4/IC31 and BCG revaccination in healthy adolescents	South Africa	Recruiting participants
M72/AS01	NCT01098474	To evaluate the safety and immunogenicity of M72/AS01in healthy infants	Gambia	Completed

^aReferenced from the website of ClinicalTrials.gov.